Clinical Trials Logo

Heart Diseases clinical trials

View clinical trials related to Heart Diseases.

Filter by:

NCT ID: NCT01804439 Completed - Heart Failure Clinical Trials

Risk Factors in the Initial Presentation of Specific Cardiovascular Disease Syndromes

Start date: January 1997
Phase: N/A
Study type: Observational [Patient Registry]

Cardiovascular disease (CVD) is an important public health problem that affects millions of people worldwide. Associations between risk factors, such as smoking, dyslipidaemia or hypertension, and prevalent CVD are well documented. However, few studies have investigated associations with onset of disease. The initial manifestation of CVD, for example an episode of unstable angina, is important because it influences the prognosis, the quality of life and the management of disease. Furthermore, the extent to which social deprivation, alcohol consumption or atrial fibrillation affects presentation of CVD is poorly understood and deserves further consideration. Most previous studies have considered CVD as a single entity. However, differences in aetiology between coronary phenotypes suggest that risk factors may not be shared across specific coronary phenotypes and their relative importance is likely to differ for each phenotype. Gaining knowledge of these differences could provide insights into the pathophysiology of specific forms of CVD and could eventually lead to modification of recommendations for patient management and disease prevention. We propose to use the linkage of the national registry of coronary events to general practice records in the Clinical Practice Research Database (CPRD), to investigate whether demographic, behavioral, and clinico-metabolic risk factors differentially influence the onset of specific types of CVD.

NCT ID: NCT01803529 Completed - Pain Clinical Trials

Deep Friction Massage for Intercostal Pain in Patients With Heart Disease

Start date: October 2003
Phase: N/A
Study type: Interventional

Studies show that chest pain is a common complaint presented in both general practice and in emergency units. Musculoskeletal causes are common, but frequently overlooked. No studies about treatment of chest pain from the intercostal muscles were found by search in medical literature databases. The purpose of this study is to evaluate the effect of two different physical therapy interventions on intercostal pain in patients with stable heart disease. The hypothesis was that deep friction massage combined with heat-pack is more effective than heat-pack only.

NCT ID: NCT01803438 Completed - Clinical trials for Symptomatic Paroxysmal Atrial Fibrillation Without Clinically Significant Heart Diseases

Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation

Start date: June 2014
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of Pulmonary Vein Isolation (PVI) performed with the Arctic Front™ Advance Cardiac CryoAblation Catheter System as first-line therapy in comparison with antiarrhythmic drugs (AAD) in patients with paroxysmal atrial fibrillation (AF).

NCT ID: NCT01796353 Completed - Sexual Dysfunction Clinical Trials

Effects of a Comprehensive Sexual Rehabilitation Programme in Heart Patients

CopenHeartSF
Start date: February 2013
Phase: N/A
Study type: Interventional

The objective is to investigate the effect of a comprehensive sexual rehabilitation program, consisting of a psycho-educative component and a physical exercise component. The primary hypothesis is that, a comprehensive sexual rehabilitation program improves sexual function.

NCT ID: NCT01794884 Completed - Clinical trials for Coronary Heart Disease

Validity Study of Glutamine to Improve Cardiac Function in Cardiac Surgery

Start date: January 2013
Phase: Phase 2
Study type: Interventional

In view of the lack of large-scale clinical study and potent evidence-based medicine, the investigators designed a randomized, double-blind, placebo-controlled study to ascertain whether preoperative intravenous administration with glutamine can improve the postoperative cardiac function and prognosis of adult patients undergoing cardiac surgery. The investigators want to detect the levels of myocardial protein O-GlcNAc modification and HSP70 expression, changes in sensitive indicators of myocardial injury, systemic inflammatory reaction and oxidative stress levels, and to examine the correlation between these changes and Clinical manifestations. The ultimate goal of the study is to explore a new way for clinical myocardial protection.

NCT ID: NCT01789554 Completed - Heart Diseases Clinical Trials

The Use of Mobile Phones in Out of Hospital Cardiac Arrest to Increase Bystander CPR

RUMBA
Start date: October 2012
Phase: N/A
Study type: Interventional

Death from cardiac disease is one of the most common causes of death in the western world. The majority of these deaths takes place outside hospital as sudden cardiac death. However, with immediate (within minutes) actions such as cardiopulmonary resuscitation (CPR) and defibrillation many lives would be saved. CPR is a key factor to increase survival from Out of Hospital Cardiac Arrest (OHCA). CPR buys time by supporting the brain with some circulation in waiting for a defibrillator that can restart the heart. In Sweden about 2,5 million people are trained in CPR. However, only about half of all OHCA victims will get CPR in waiting for ambulance arrival. The aims of the Response to Urgent Mobile message for Bystander Activation (RUMBA) trial is to try a new way of logistics to increase bystander CPR by recruiting lay volunteers to nearby OHCAs via their mobile phones. Hypothesis: By dispatching lay volunteers to nearby OHCAs with mobile phone technology bystander CPR may increase from 50% to 62,5 %

NCT ID: NCT01784055 Completed - Clinical trials for Cardiovascular Diseases

NeoChord TACT Post-Market Surveillance Registry

Start date: March 2013
Phase:
Study type: Observational [Patient Registry]

To monitor the long-term performance of the CE Marked NeoChord Artificial Chordae Delivery System

NCT ID: NCT01782716 Completed - Heart Diseases Clinical Trials

Effect of Different Scoring Systems on Mortality Rates and Length of Hospitalization in Cardiac Surgery Patients

Start date: January 2012
Phase: N/A
Study type: Observational

Precise risk estimation of mortality in cardiac surgery patients is often difficult. Main objectives of this study is to calculate mortality probability by two different risk score system and to inquire effects of informing anesthesiologist and surgical team; of score of the patient; on length of hospitalization and intensive care and also on actualized mortality.

NCT ID: NCT01779869 Completed - Clinical trials for Ischemic Heart Disease

Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson

PET/MR-P
Start date: January 2013
Phase: Phase 4
Study type: Interventional

The objective for this pilot study is to develop an optimized, clinically usable myocardial PET-MR perfusion protocol and to determine which of all data potentially available should be acquired for a clinical myocardial perfusion examination. Hypothesis: The hypothesis is that high resolution, high sensitivity DCE MRI could replace the rest PET myocardial perfusion imaging, significantly decreasing examination time and patient radiation dose while maintaining the comprehensive reference-quality PET myocardial stress perfusion coverage. The primary outcome will be comparison of diagnostic accuracy of each combination of imaging to detect clinically significant coronary artery stenosis (≥70% diameter stenosis).

NCT ID: NCT01779401 Completed - Clinical trials for Coronary Heart Disease

Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients

CREATIVE
Start date: September 2012
Phase: N/A
Study type: Interventional

To identify the high-risk patients who might have in-stent thrombosis after PCI with thromboelastography and to head-to-head compare two intensified antiplatelet therapeutic strategies of double-dosage Clopidogrel and triple antiplatelet therapy with Cilostazol with the standard antiplatelet therapy.